Organ protection beyond glycaemic control with SGLT2 inhibitors
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Text and Data Mining valid from 2020-11-06
Version of Record valid from 2020-11-06
6 November 2020
C.P. is an Advisory Board member for Astra Zeneca and Boehringer Ingelheim, and a member of the Steering Committee of CREDENCE. U.P. declares no competing interests.